Concentrations of tenofovir, lamivudine and efavirenz in mothers and children enrolled under the Option B-Plus approach in Malawi.
暂无分享,去创建一个
S. Mancinelli | L. Palombi | M. Giuliano | S. Vella | R. Luhanga | S. Pichini | G. Liotta | M. Marazzi | E. Marchei | M. Floridia | M. Pirillo | C. Galluzzo | M. Andreotti | J. Sagno | H. Jere | R. Mwenda
[1] S. Khoo,et al. Breast milk pharmacokinetics of efavirenz and breastfed infants' exposure in genetically defined subgroups of mother-infant pairs: an observational study. , 2015, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[2] L. Aurpibul,et al. Review of tenofovir use in HIV-infected children. , 2015, The Pediatric infectious disease journal.
[3] W. Stevens,et al. High Prevalence of the K65R Mutation in HIV-1 Subtype C Infected Patients Failing Tenofovir-Based First-Line Regimens in South Africa , 2015, PloS one.
[4] S. Khoo,et al. Development, validation and clinical application of a novel method for the quantification of efavirenz in dried breast milk spots using LC-MS/MS. , 2015, The Journal of antimicrobial chemotherapy.
[5] M. Hudgens,et al. Antiretroviral Pharmacokinetics in Mothers and Breastfeeding Infants from 6 to 24 Weeks Post-Partum: Results of the Ban Study , 2014, Antiviral therapy.
[6] L. Mofenson,et al. Pharmacokinetics and Safety of Tenofovir in HIV-Infected Women During Labor and Their Infants During the First Week of Life , 2014, Journal of acquired immune deficiency syndromes.
[7] R. Chaisson,et al. Resistance to Tenofovir-Based Regimens during Treatment Failure of Subtype C HIV-1 in South Africa , 2013, Antiviral therapy.
[8] D. Havlir,et al. Hair and Plasma Data Show That Lopinavir, Ritonavir, and Efavirenz All Transfer From Mother to Infant In Utero, But Only Efavirenz Transfers via Breastfeeding , 2013, Journal of acquired immune deficiency syndromes.
[9] Simon A. A. Travers,et al. Trends in Genotypic HIV-1 Antiretroviral Resistance between 2006 and 2012 in South African Patients Receiving First- and Second-Line Antiretroviral Treatment Regimens , 2013, PloS one.
[10] E. Schouten,et al. Impact of an Innovative Approach to Prevent Mother-to-Child Transmission of HIV — Malawi, July 2011–September 2012 , 2013, MMWR. Morbidity and mortality weekly report.
[11] L. Palombi,et al. Antiretroviral Prophylaxis for Breastfeeding Transmission in Malawi: Drug Concentrations, Virological Efficacy and Safety , 2012, Antiviral therapy.
[12] D. Kuritzkes,et al. High rate of K65R for antiretroviral therapy-naive patients with subtype C HIV infection failing a tenofovir-containing first-line regimen , 2012, AIDS.
[13] B. Fríguls,et al. Simultaneous analysis of frequently used licit and illicit psychoactive drugs in breast milk by liquid chromatography tandem mass spectrometry. , 2011, Journal of pharmaceutical and biomedical analysis.
[14] F. Dabis,et al. Concentrations of Tenofovir and Emtricitabine in Breast Milk of HIV-1-Infected Women in Abidjan, Côte d'Ivoire, in the ANRS 12109 TEmAA Study, Step 2 , 2010, Antimicrobial Agents and Chemotherapy.
[15] H. Kruger,et al. Efavirenz plasma concentrations at 1, 3, and 6 months post-antiretroviral therapy initiation in HIV type 1-infected South African children. , 2010, AIDS research and human retroviruses.
[16] M. Fowler,et al. Antiretroviral Concentrations in Breast-Feeding Infants of Mothers Receiving Highly Active Antiretroviral Therapy , 2008, Antimicrobial Agents and Chemotherapy.
[17] V. Arendt,et al. Efavirenz in Human Breast Milk, Mothers', and Newborns' Plasma , 2008, Journal of acquired immune deficiency syndromes.
[18] A. Tremoulet,et al. Population Pharmacokinetics of Lamivudine in Human Immunodeficiency Virus-Exposed and -Infected Infants , 2007, Antimicrobial Agents and Chemotherapy.
[19] S. Lockman,et al. Antiretroviral concentrations in breast-feeding infants of women in Botswana receiving antiretroviral treatment. , 2005, The Journal of infectious diseases.